Works matching DE "CYPROTERONE acetate"

Results: 170

Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.

Published in:

Archives of Gynecology & Obstetrics, 2014, v. 290, n. 2, p. 321, doi. 10.1007/s00404-014-3217-5

By:

Kahraman, Korhan;
Şükür, Yavuz;
Atabekoğlu, Cem;
Ateş, Can;
Taşkın, Salih;
Çetinkaya, Şerife;
Tolunay, Harun;
Özmen, Batuhan;
Sönmezer, Murat;
Berker, Bülent

Publication type:

Article

Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.

Published in:

Archives of Gynecology & Obstetrics, 2014, v. 289, n. 1, p. 135, doi. 10.1007/s00404-013-2960-3

By:

Karakurt, Feridun;
Carlioglu, Ayse;
Kaygusuz, Ikbal;
Gumus, Ilknur;
Uz, Burak;
Akdeniz, Derya

Publication type:

Article

Hormone replacement therapy: relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women.

Published in:

Archives of Gynecology & Obstetrics, 2012, v. 285, n. 3, p. 733, doi. 10.1007/s00404-011-2051-2

By:

Gökkuşu, Cahide;
Özbek, Zeynep;
Tata, Gülten

Publication type:

Article

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate.

Published in:

Archives of Gynecology & Obstetrics, 2011, v. 284, n. 4, p. 923, doi. 10.1007/s00404-010-1790-9

By:

Gode, Funda;
Karagoz, Cigdem;
Posaci, Cemal;
Saatli, Bahadir;
Uysal, Didem;
Secil, Mustafa;
Akdeniz, Bahri

Publication type:

Article

Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.

Published in:

Archives of Gynecology & Obstetrics, 2010, v. 281, n. 3, p. 539, doi. 10.1007/s00404-009-1189-7

By:

Kebapcilar, Levent;
Bilgir, Oktay;
Taner, Cuneyt Eftal;
Kebapcilar, Ayse Gul;
Kozaci, Didem L.;
Alacacioglu, Ahmet;
Yildiz, Yasar;
Yuksel, Arif;
Sari, Ismail

Publication type:

Article

Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.

Published in:

Archives of Gynecology & Obstetrics, 2010, v. 281, n. 1, p. 35, doi. 10.1007/s00404-009-1051-y

By:

Kebapcilar, Levent;
Taner, Cuneyt;
Kebapcilar, Ayse;
Alacacioglu, Ahmet;
Sari, Ismail

Publication type:

Article

Simultaneous Measurement of Serum Chemical Castration Agents and Testosterone Levels Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry.

Published in:

Journal of Analytical Toxicology, 2016, v. 40, n. 4, p. 294, doi. 10.1093/jat/bkw017

By:

Dae-Hyun Ko;
Kyunghoon Lee;
Sun-Hee Jeona;
Sang Hoon Song;
Yeo-Min Yun;
Sail Chun;
Hee Seung Kim;
Jin Young Kim;
Moon Kyo In;
Junghan Song

Publication type:

Article

P-1336 - Agonists LHRH treatment of sex offenders

Published in:

2012

By:

Catrin, E.

Publication type:

Abstract

Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics

Published in:

European Psychiatry, 2002, v. 17, n. 2, p. 104, doi. 10.1016/S0924-9338(02)00635-1

By:

Czerny, J.-P.;
Briken, P.;
Berner, W.

Publication type:

Article

Anion binding by pyrrole-pyridine-based macrocyclic polyamides.

Published in:

Supramolecular Chemistry, 2008, v. 20, n. 7, p. 619, doi. 10.1080/10610270701561342

By:

Katayev, E.A.;
Myshkovskaya, E.N.;
Boev, N.V.;
Khrustalev, V.N.

Publication type:

Article

Effect of Treatment with Cyproterone Acetate on Uterine Bleeding at the Beginning of GnRH Analogue Therapy in Girls with Idiopathic Central Precocious Puberty.

Published in:

Hormone Research in Paediatrics, 2010, v. 73, n. 5, p. 386, doi. 10.1159/000308172

By:

Seminara;
Nanni;
Generoso;
Mirri;
Leonardi;
Slabadzianiuk;
Vetrano;
Buongiorno;
Losi;
Galluzzi

Publication type:

Article

Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.

Published in:

Pharmaceutical Medicine, 2017, v. 31, n. 5, p. 339, doi. 10.1007/s40290-017-0203-9

By:

Davis, Kimberly;
Asiimwe, Alex;
Zografos, Laurie;
McSorley, David;
Andrews, Elizabeth

Publication type:

Article

Complicaciones provocadas por los anticonceptivos orales combinados. Eventos tromboembólicos.

Published in:

Ginecología y Obstetricia de México, 2020, v. 88, p. S140, doi. 10.24245/gom.v88i-Supl1.3852

By:

Gómez-Tabares, Gustavo

Publication type:

Article

Finasteride versus cyproterone acetate–estrogen regimens in the treatment of hirsutism

Published in:

2004

By:

Beigi, A.;
Sobhi, A.;
Zarrinkoub, F.

Publication type:

journal article

Cyproterone to treat aggressivity in dementia: a clinical case and systematic review.

Published in:

Journal of Psychopharmacology, 2011, v. 25, n. 1, p. 141, doi. 10.1177/0269881109353460

By:

Bolea-Alamanac, Blanca M.;
Davies, Simon J. C.;
Christmas, David M.;
Baxter, Hazel;
Cullum, Sarah;
Nutt, David J.

Publication type:

Article

Au fil de la presse.

Published in:

Médecine, 2023, v. 19, n. 3, p. 103, doi. 10.1684/med.2023.861

By:

Casassus, Philippe

Publication type:

Article

Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.

Published in:

Journal of the Royal Society of Medicine, 1986, v. 79, n. 4, p. 210, doi. 10.1177/014107688607900407

By:

Paisey, R. B.;
Kadow, C.;
Bolton, C.;
Hartog, M.;
Gingell, J. C.

Publication type:

Article

In the Public Eye.

Published in:: Urology Times, 2001, v. 29, n. 1, p. 23
Publication type:: Article

Cre- lox66/ lox71-Based Elimination of Phosphotransacetylase or Acetaldehyde Dehydrogenase Shifted Carbon Flux in Acetogen Rendering Selective Overproduction of Ethanol or Acetate.

Published in:

Applied Biochemistry & Biotechnology, 2012, v. 168, n. 6, p. 1384, doi. 10.1007/s12010-012-9864-8

By:

Berzin, Vel;
Kiriukhin, Michael;
Tyurin, Michael

Publication type:

Article

Cyproterone Synthesis, Recognition and Controlled Release by Molecularly Imprinted Nanoparticle.

Published in:

Applied Biochemistry & Biotechnology, 2012, v. 167, n. 7, p. 2076, doi. 10.1007/s12010-012-9748-y

By:

Asadi, Ebadullah;
Azodi-Deilami, Saman;
Abdouss, Majid;
Khaghani, Saeedeh

Publication type:

Article

Nongenomic effect of androgens on Ca<sup>2+</sup> concentration in human lymphocytes.

Published in:

Bulletin of Experimental Biology & Medicine, 2007, v. 143, n. 5, p. 605, doi. 10.1007/s10517-007-0193-9

By:

N. Popova;
A. Dukhanin;
N. Shimanovskii

Publication type:

Article

Efficacy of combined ethinyloestradiol (0.035 mg) and...

Published in:

Journal of Obstetrics & Gynaecology, 1997, v. 17, n. 6, p. 565, doi. 10.1080/01443619768623

By:

Falsetti, L.;
Ramazzotto, Francesca;
Rosina, Barbara

Publication type:

Article

Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.

Published in:

British Journal of Dermatology, 2016, v. 175, n. 1, p. 45, doi. 10.1111/bjd.14486

By:

Zuuren, E.J.;
Fedorowicz, Z.

Publication type:

Article

Is hormonal treatment still an option in acne today?

Published in:

British Journal of Dermatology, 2015, v. 172, p. 37, doi. 10.1111/bjd.13681

By:

Bettoli, V.;
Zauli, S.;
Virgili, A.

Publication type:

Article

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.

Published in:

British Journal of Dermatology, 2002, v. 146, n. 6, p. 992, doi. 10.1046/j.1365-2133.2002.04798.x

By:

Vexiau, P.;
Chaspoux, C.;
Boudou, P.;
Fiet, J.;
Jouanique, C.;
Hardy, N.;
Reygagne, P.

Publication type:

Article

Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 72, n. 6, p. 965, doi. 10.1111/j.1365-2125.2011.04031.x

By:

Gil, Miguel;
Oliva, Belén;
Timoner, Julia;
Maciá, Miguel A.;
Bryant, Verónica;
de Abajo, Francisco J.

Publication type:

Article

Epidemiology and Treatment of Juvenile Sexual Offending.

Published in:

Pediatric Drugs, 2004, v. 6, n. 2, p. 79, doi. 10.2165/00148581-200406020-00002

By:

Gerardin, Priscille;
Thibaut, Florence

Publication type:

Article

Null Effect of Dietary Restriction on Prostate Carcinogenesis in the Wistar-Unilever Rat.

Published in:

Nutrition & Cancer, 2007, v. 57, n. 2, p. 194, doi. 10.1080/01635580701277494

By:

McCormick, DavidL.;
Johnson, WilliamD.;
Haryu, ToddM.;
Bosland, MaartenC.;
Lubet, RonaldA.;
Steele, VernonE.

Publication type:

Article

Chemoprevention of Rat Prostate Carcinogenesis by Soy Isoflavones and by Bowman-Birk Inhibitor.

Published in:

Nutrition & Cancer, 2007, v. 57, n. 2, p. 184, doi. 10.1080/01635580701277478

By:

McCormick, DavidL.;
Johnson, WilliamD.;
Bosland, MaartenC.;
Lubet, RonaldA.;
Steele, VernonE.

Publication type:

Article

Local Suppression of Sebum Secretion in Rats by Topical Cyproterone Acetate in Ethanol.

Published in:

Journal of Investigative Dermatology, 1981, v. 77, n. 6, p. 458, doi. 10.1111/1523-1747.ep12497595

By:

Ebling, F. J.;
Randall, Valerie A.;
Skinner, J.

Publication type:

Article

Risk of VTE with Oral Contraceptives.

Published in:

OB/GYN Clinical Alert, 2009, v. 26, n. 7, p. 52

By:

Jensen, Jeffrey T.

Publication type:

Article

The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.

Published in:

Pharmacoepidemiology & Drug Safety, 2003, v. 12, n. 7, p. 541, doi. 10.1002/pds.857

By:

H. E. Seaman;
C. S. de Vries;
R. D. T. Farmer

Publication type:

Article

Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate.

Published in:

British Journal of Dermatology, 1973, v. 89, n. 5, p. 487, doi. 10.1111/j.1365-2133.1973.tb03009.x

By:

Burton, J.L.;
Laschet, Ursula;
Shuster, Sam

Publication type:

Article

THE TOPICAL EFFECT OF THE ANTIANDROGEN CHLORMADIN- ONE ACETATE AND SOME OF ITS CHEMICAL MODIFICATIONS ON THE HAMSTER COSTOVERTEBRAL ORGAN.

Published in:

British Journal of Dermatology, 1970, v. 82, p. 19, doi. 10.1111/j.1365-2133.1970.tb08001.x

By:

Burdick, Kenneth H.;
Hill, Robert

Publication type:

Article

THE EFFECT OF TOPICAL CYPROTERONE ACETATE ON SEBUM SECRETION IN PATIENTS WITH ACNE.

Published in:

British Journal of Dermatology, 1969, v. 81, n. 3, p. 200, doi. 10.1111/j.1365-2133.1969.tb16007.x

By:

Cunliffe, W. J.;
Shuster, Sam;
Cassels Smith, A. J.

Publication type:

Article

HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN HUMAN SKIN II. FACTORS INFLUENCING HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN SEBACEOUS GLANDS OF HUMAN SKIN.

Published in:

British Journal of Dermatology, 1968, v. 80, n. 10, p. 652, doi. 10.1111/j.1365-2133.1968.tb11915.x

By:

Muir, A. V.;
Calman, K. C.;
Thomson, J.;
Macsween, M. P.;
Milne, J. A.;
Chakraborty, J.;
Grant, J. K.

Publication type:

Article

Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.

Published in:

1999

By:

Ishii, T.;
Sato, S.;
Anzo, M.;
Sasaki, G.;
Hasegawa, T.;
Tamai, S.;
Matsuo, N.

Publication type:

journal article

Cirrhosis in a child with hypothalamic syndrome and central precocious puberty treated with cyproterone acetate.

Published in:

1999

By:

Garty, B. Z.;
Dinari, G.;
Gellvan, A.;
Kauli, R.

Publication type:

journal article

The Anti-Fertility and Cytotoxicity Effects of Cyproterone Acetate and Phenolic Extract of Hibiscusrosa Sinensis Linn Flowers in Male Albino Rats.

Published in:

Indian Journal of Public Health Research & Development, 2018, v. 9, n. 7, p. 177, doi. 10.5958/0976-5506.2018.00635.6

By:

Al-Saily, H. M.;
Al-Hady, F. N.;
Al-Halbosiy, M. M.

Publication type:

Article

Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill.

Published in:

Hormone Molecular Biology & Clinical Investigation, 2010, v. 3, n. 3, p. 441, doi. 10.1515/HMBCI.2010.062

By:

Maitrot-Mantelet, Lorraine;
Agopian, Anahid;
Gompel, Anne

Publication type:

Article

The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women.

Published in:

Platelets, 2010, v. 21, n. 6, p. 439, doi. 10.3109/09537104.2010.481475

By:

Gokkusu, Cahide;
Tata, Gulten;
Ademoğlu, Evin;
Tamer, Sule

Publication type:

Article

Sintering Behaviour of ZnO:Cu Ceramics Fabricated by Sol--Gel Derived Powders.

Published in:

Acta Physica Polonica: A, 2012, v. 121, n. 1, p. 271

By:

Bahşi, Z. B.;
Oral, A. Y.;
Aslan, M. H.;
Kayahan, E.;
Ozer, M.

Publication type:

Article

Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.

Published in:

2018

By:

Mancini, Ilaria;
Rotilio, Antonino;
Coati, Irene;
Seracchioli, Renato;
Martelli, Valentina;
Meriggiola, Maria Cristina

Publication type:

Case Study

Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?

Published in:

Gynecological Endocrinology, 2016, v. 32, n. 8, p. 612, doi. 10.3109/09513590.2016.1145647

By:

Plouvier, Pauline;
Peigné, Maëliss;
Gronier, Héloïse;
Robin, Geoffroy;
Catteau-Jonard, Sophie;
Dewailly, Didier

Publication type:

Article

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.

Published in:

Gynecological Endocrinology, 2012, v. 28, n. 5, p. 400, doi. 10.3109/09513590.2012.662547

By:

Fruzzetti, Franca;
Trémollieres, Florence;
Bitzer, Johannes

Publication type:

Article

Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.

Published in:

Gynecological Endocrinology, 2012, v. 28, n. 4, p. 245, doi. 10.3109/09513590.2011.613971

By:

Karabulut, Aysun;
Demirlenk, Semra;
Şevket, Osman

Publication type:

Article

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.

Published in:

Gynecological Endocrinology, 2011, v. 27, n. 12, p. 971, doi. 10.3109/09513590.2011.569783

By:

Markantes, George;
Saltamavros, Alexandros D.;
Vervita, Vasiliki;
Armeni, Anastasia K.;
Karela, Anastasia;
Adonakis, George;
Decavalas, George;
Georgopoulos, Neoklis A.

Publication type:

Article

Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.

Published in:

Gynecological Endocrinology, 2011, v. 27, n. 9, p. 615, doi. 10.3109/09513590.2010.521265

By:

Naka, Katerina K.;
Kalantaridou, Sophia N.;
Bechlioulis, Aris;
Kravariti, Maria;
Kazakos, Nikolaos;
Katsouras, Christos S.;
Tsatsoulis, Agathocles;
Michalis, Lampros K

Publication type:

Article

Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism.

Published in:

Gynecological Endocrinology, 2007, v. 23, n. 1, p. 38, doi. 10.1080/09637480601137066

By:

Batukan, Cem;
Muderris, Iptisam Ipek;
Ozcelik, Bulent;
Ozturk, Ahmet

Publication type:

Article

ANTIANDROGEN THERAPY IN DERMATOLOGY.

Published in:

International Journal of Dermatology, 1996, v. 35, n. 11, p. 770, doi. 10.1111/j.1365-4362.1996.tb02970.x

By:

Shaw, James C.

Publication type:

Article